Uri Lopatin, MD

Overview

Uri Lopatin is an Operating Partner at Khosla Ventures [1] and a physician-scientist and biotech entrepreneur with a passion for translational science and medicine [2]. Lopatin currently serves as CEO of Ukko [3] while maintaining the Operating Partner role at Khosla Ventures [4]. Previously, Lopatin founded Pardes Biosciences, serving as CEO and President from February 2020 to March 2022 [7], then as Founder, Board Member, and Strategic and Scientific Advisor from March 2022 to August 2023 [6]. Lopatin has also held advisory roles at Assembly Biosciences [10] and served as a Visiting Partner and later Expert in Bio at Y Combinator [9][8]. Lopatin is a Fellow of the Edmund Hillary Fellowship [5]. Lopatin's medical training includes an Internal Medicine Residency at New York University [12], an internship at the University of Washington School of Medicine [13], and an Infectious Disease Fellowship at the National Institutes of Health [11].

Career history

1. UCEONov 2024 to presentUkko
2. Operating PartnerAug 2023 to presentKhosla Ventures
3. EHFellowOct 2020 to presentEdmund Hillary Fellowship (EHF)
4. PBFounder, Board Member, Strategic and Scientific AdvisorMar 2022 to Aug 2023Pardes Biosciences
5. PBFounder, CEO and PresidentFeb 2020 to Mar 2022Pardes Biosciences
6. Expert - BioNov 2020 to Aug 2023Y Combinator
7. Visiting PartnerJun 2019 to Nov 2020Y Combinator
8. ABScientific & Strategic AdvisorMay 2019 to Mar 2022Assembly Biosciences, Inc.

Education

1. IFID Fellowship at National Institutes of Health2003 - 2006
2. Residency, Internal Medicine Residency Program2001 - 2003New York University
3. Internship2000 - 2001University of Washington·School of Medicine